Hepatitis B Trial, Recruiting NCT00404989 Sponsor: Syneos Health Condition: Hepatitis B
Back to Hepatitis B

Hepatitis B Trial, Recruiting

NCT00404989
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of childbearing potential who took the registry medication during pregnancy
  • Cases where the country where the report originates can be documented
  • Cases where there is clear documentation that the registry drug was taken during pregnancy
  • Cases where it can be determined whether the pregnancy was registered before or after the outcome was known
  • Cases where the date the pregnancy was registered is available
  • Cases where the source of the report (either the patient or a healthcare provider) is known
  • Cases where it is known whether the pregnancy has already ended or is still ongoing
  • Cases where the timing of when the medication was taken during pregnancy is known (at least which trimester)
  • Cases where enough identifying information is available to allow the trial team to follow up
  • Cases where it is known whether the patient was in another study at the time of the pregnancy exposure
  • Cases where full contact details for the person making the report are available (name, address, etc.)

Who may not be able to join:

  • People who were not exposed to the registry medications during pregnancy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jessica D Albano, PhD, MPH, Syneos Health

Phone: 800-258-4263

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Syneos Health
Registry
ClinicalTrials.gov
Start date
1 January 1989
Est. completion
1 January 2099

Where this trial is recruiting

🇺🇸 United States

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov